Suneel Gupta
Chief Development Officer · Protagonist Therapeutics, Inc
- 2024
- Nov 27, 2024
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Suneel Gupta files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Dinesh V. Ph D. Patel - $60.58M in PTGX purchases and sales in the last 12 months
- Asif Ali - $15.63M in PTGX purchases and sales in the last 12 months
- Bryan Giraudo - $5.92M in PTGX purchases and sales in the last 12 months
- William D. Waddill - $4.60M in PTGX purchases and sales in the last 12 months
- Arturo Md Molina - $4.49M in PTGX purchases and sales in the last 12 months
- Harold E. Selick - $2.52M in PTGX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Suneel Gupta?
Suneel Gupta is a corporate insider, tracked as Chief Development Officer of Protagonist Therapeutics, Inc (PTGX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Suneel Gupta last file a Form 4?
The only primary Form 4 on record is dated 27 November 2024.
Has Suneel Gupta been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($5.64M) across all tracked filings.
